Fludarabine/Clofarabine/Busulfan combined with SAHA in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

Trial Profile

Fludarabine/Clofarabine/Busulfan combined with SAHA in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation for Acute Leukemia

Recruiting
Phase of Trial: Phase I

Latest Information Update: 12 May 2017

At a glance

  • Drugs Vorinostat (Primary) ; Busulfan; Clofarabine; Fludarabine
  • Indications Acute lymphoblastic leukaemia; Acute myeloid leukaemia; Leukaemia; Myelodysplastic syndromes
  • Focus Adverse reactions
  • Acronyms SAHA
  • Most Recent Events

    • 14 Mar 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top